相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Probiotics for Constipation in Parkinson Disease A Randomized Placebo-Controlled Study
Ai Huey Tan et al.
NEUROLOGY (2021)
Meta-analysis of the Parkinson's disease gut microbiome suggests alterations linked to intestinal inflammation
Stefano Romano et al.
NPJ PARKINSONS DISEASE (2021)
Evaluation of fecal microbiota transplantation in Parkinson's disease patients with constipation
Xiao-yi Kuai et al.
MICROBIAL CELL FACTORIES (2021)
The gut vascular barrier: a new player in the gut-liver-brain axis
Paola Brescia et al.
TRENDS IN MOLECULAR MEDICINE (2021)
Gastroparesis in Parkinson Disease: Pathophysiology, and Clinical Management
Heithem Soliman et al.
BRAIN SCIENCES (2021)
Association between Anticholinergic Burden and Constipation: A Systematic Review
Hector Rodriguez-Ramallo et al.
HEALTHCARE (2021)
A GLP-2 Analogue Protects SH-SY5Y and Neuro-2a Cells Against Mitochondrial Damage, Autophagy Impairments and Apoptosis in a Parkinson Model
Yunfang Su et al.
DRUG RESEARCH (2021)
Neuroprotective Effect of Quercetin in Combination with Piperine Against Rotenone- and Iron Supplement-Induced Parkinson's Disease in Experimental Rats
Shakshi Sharma et al.
NEUROTOXICITY RESEARCH (2020)
Metformin Reduces Aging-Related Leaky Gut and Improves Cognitive Function by Beneficially Modulating Gut Microbiome/Goblet Cell/Mucin Axis
Shokouh Ahmadi et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2020)
Autonomic dysfunction in Parkinson's disease: Implications for pathophysiology, diagnosis, and treatment
Zhichun Chen et al.
NEUROBIOLOGY OF DISEASE (2020)
Neuroprotective Effects of Quercetin in Alzheimer's Disease
Haroon Khan et al.
BIOMOLECULES (2020)
How adding the abdominal massage to polyethylene glycol can improve symptom and quality of life in patients with functional constipation in comparison with each one of the treatment modalities alone: A randomized clinical trial
Marjan Mokhtare et al.
COMPLEMENTARY THERAPIES IN MEDICINE (2020)
Prevalence and Risk Factors for Malnutrition in Patients With Parkinson's Disease
Tianting Yang et al.
FRONTIERS IN NEUROLOGY (2020)
Fecal microbiota transplantation to treat Parkinson's disease with constipation A case report
Hongli Huang et al.
MEDICINE (2019)
Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
Klaus Seppi et al.
MOVEMENT DISORDERS (2019)
Metformin protects against intestinal barrier dysfunction via AMPKα1-dependent inhibition of JNK signalling activation
Jun Deng et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
The Nasal and Gut Microbiome in Parkinson's Disease and Idiopathic Rapid Eye Movement Sleep Behavior Disorder
Anna Heintz-Buschart et al.
MOVEMENT DISORDERS (2018)
Enteric nervous system manifestations of neurodegenerative disease
Alcmene Chalazonitis et al.
BRAIN RESEARCH (2018)
Inoculation of α-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve
Norihito Uemura et al.
MOLECULAR NEURODEGENERATION (2018)
Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology
Fredric P. Manfredsson et al.
NEUROBIOLOGY OF DISEASE (2018)
Low body mass index and life prognosis in Parkinson's disease
Kwiyoung Park et al.
PARKINSONISM & RELATED DISORDERS (2018)
The Therapeutic Potential of Metformin in Neurodegenerative Diseases
Carola Rotermund et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Metformin Use Associated with Reduced Risk of Dementia in Patients with Diabetes: A Systematic Review and Meta-Analysis
Jared M. Campbell et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
The burden of Parkinson's disease: a worldwide perspective
Walter A. Rocca
LANCET NEUROLOGY (2018)
Linaclotide and Prucalopride for Management of Constipation in Patients with Parkinsonism
Maria Eliza Freitas et al.
MOVEMENT DISORDERS CLINICAL PRACTICE (2018)
Constipation in Parkinson's Disease: Subjective Symptoms, Objective Markers, and New Perspectives
Karoline Knudsen et al.
MOVEMENT DISORDERS (2017)
Downregulation of neuronal vasoactive intestinal polypeptide in Parkinson's disease and chronic constipation
F. Giancola et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2017)
Glitazone Use Associated With Reduced Risk of Parkinson's Disease
Brage Brakedal et al.
MOVEMENT DISORDERS (2017)
Parkinson's Disease and Parkinson's Disease Medications Have Distinct Signatures of the Gut Microbiome
Erin M. Hill-Burns et al.
MOVEMENT DISORDERS (2017)
Neuroprotective potential of Quercetin in combination with piperine against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity
Shamsher Singh et al.
NEURAL REGENERATION RESEARCH (2017)
A practical review of gastrointestinal manifestations in Parkinson's disease
Andrew Su et al.
PARKINSONISM & RELATED DISORDERS (2017)
Progression of Parkinson's disease is associated with gut dysbiosis: Two-year follow-up study
Tomomi Minato et al.
PLOS ONE (2017)
Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naive Parkinson's disease patients
J. R. Bedarf et al.
GENOME MEDICINE (2017)
Objective Colonic Dysfunction is Far more Prevalent than Subjective Constipation in Parkinson's Disease: A Colon Transit and Volume Study
Karoline Knudsen et al.
JOURNAL OF PARKINSONS DISEASE (2017)
An update on prucalopride in the treatment of chronic constipation
Anam Omer et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2017)
Dietary habits and neurological features of Parkinson's disease patients: Implications for practice
Michela Barichella et al.
CLINICAL NUTRITION (2017)
Polyphenols Beyond Barriers: A Glimpse into the Brain
Ines Figueira et al.
CURRENT NEUROPHARMACOLOGY (2017)
Glucagon-like peptide 2 counteracts the mucosal damage and the neuropathy induced by chronic treatment with cisplatin in the mouse gastric fundus
A. Pini et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2016)
Prucalopride exerts neuroprotection in human enteric neurons
Francesca Bianco et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2016)
Ameliorative Effect of Quercetin on Neurochemical and Behavioral Deficits in Rotenone Rat Model of Parkinson's Disease: Modulating Autophagy (Quercetin on Experimental Parkinson's Disease)
Hemat E. El-Horany et al.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2016)
A novel dual GLP-1 and GIP incretin receptor agonist is neuroprotective in a mouse model of Parkinson's disease by reducing chronic inflammation in the brain
Lijun Cao et al.
NEUROREPORT (2016)
Levodopa responsiveness of dysphagia in advanced Parkinson's disease and reliability testing of the FEES-Levodopa-test
Tobias Warnecke et al.
PARKINSONISM & RELATED DISORDERS (2016)
Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls
Marcus M. Unger et al.
PARKINSONISM & RELATED DISORDERS (2016)
The Pathophysiology of Chronic Constipation
Christopher N Andrews et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY (2016)
Protective Effects of Quercetin on Mitochondrial Biogenesis in Experimental Traumatic Brain Injury via the Nrf2 Signaling Pathway
Xiang Li et al.
PLOS ONE (2016)
Flavonoids: an overview
A. N. Panche et al.
JOURNAL OF NUTRITIONAL SCIENCE (2016)
Rate of aspiration pneumonia in hospitalized Parkinson's disease patients: a cross-sectional study
Daniel Martinez-Ramirez et al.
BMC NEUROLOGY (2015)
The treatment of gastroparesis, constipation and small intestinal bacterial overgrowth syndrome in patients with Parkinson's disease
Jose L. Barboza et al.
EXPERT OPINION ON PHARMACOTHERAPY (2015)
Central cholinergic dysfunction could be associated with oropharyngeal dysphagia in early Parkinson's disease
Kyung Duck Lee et al.
JOURNAL OF NEURAL TRANSMISSION (2015)
Gastrointestinal dysfunction in Parkinson's disease
Alfonso Fasano et al.
LANCET NEUROLOGY (2015)
Neuroprotective effects of 5-(4-hydroxy-3-dimethoxybenzylidene)-thiazolidinone in MPTP induced Parkinsonism model in mice
Zhili Ren et al.
NEUROPHARMACOLOGY (2015)
Brain-gut-microbiota axis in Parkinson's disease
Agata Mulak et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Structural alterations of the intestinal epithelial barrier in Parkinson's disease
Thomas Clairembault et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2015)
Management of constipation in Parkinson's disease
Malco Rossi et al.
EXPERT OPINION ON PHARMACOTHERAPY (2015)
Gut Microbiota Are Related to Parkinson's Disease and Clinical Phenotype
Filip Scheperjans et al.
MOVEMENT DISORDERS (2015)
Motor and Cognitive Advantages Persist 12 Months After Exenatide Exposure in Parkinson's Disease
Iciar Aviles-Olmos et al.
JOURNAL OF PARKINSONS DISEASE (2014)
Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats
Staffan Holmqvist et al.
ACTA NEUROPATHOLOGICA (2014)
Systematic review with meta-analysis: highly selective 5-HT4 agonists (prucalopride, velusetrag or naronapride) in chronic constipation
A. Shin et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
A randomised clinical trial to evaluate the effects of Plantago ovata husk in Parkinson patients: changes in levodopa pharmacokinetics and biochemical parameters
M. Nelida Fernandez-Martinez et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2014)
Acute metformin preconditioning confers neuroprotection against focal cerebral ischaemia by pre-activation of AMPK-dependent autophagy
Teng Jiang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Premotor and nonmotor features of Parkinson's disease
Jennifer G. Goldman et al.
CURRENT OPINION IN NEUROLOGY (2014)
Mucus Layers in Inflammatory Bowel Disease
Malin E. V. Johansson
INFLAMMATORY BOWEL DISEASES (2014)
Long-Term Metformin Usage and Cognitive Function among Older Adults with Diabetes
Tze Pin Ng et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Progression of Intestinal Permeability Changes and Alpha-Synuclein Expression in a Mouse Model of Parkinson's Disease
Leo P. Kelly et al.
MOVEMENT DISORDERS (2014)
Drooling in Parkinson's disease: A review
Prachaya Srivanitchapoom et al.
PARKINSONISM & RELATED DISORDERS (2014)
Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide
Krzysztof Łabuzek et al.
Pharmacological Reports (2014)
Management of faecal incontinence and constipation in adults with central neurological diseases
Maureen Coggrave et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)
Autonomic symptoms and dopaminergic treatment in de novo Parkinson's disease
B. Muller et al.
ACTA NEUROLOGICA SCANDINAVICA (2013)
Clinical Guideline: Management of Gastroparesis
Michael Camilleri et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Quercetin supplementation is effective in improving mitochondrial dysfunctions induced by 3-nitropropionic acid: Implications in Huntington's disease
Rajat Sandhir et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Evidence for adaptive cortical changes in swallowing in Parkinson's disease
Sonja Suntrup et al.
BRAIN (2013)
Gender differences in non-motor symptoms in early, drug na⟨ve Parkinson's disease
Marina Picillo et al.
JOURNAL OF NEUROLOGY (2013)
The pros and cons of probiotics
Carrie Arnold
LANCET INFECTIOUS DISEASES (2013)
Serotonin signalling in the gut-functions, dysfunctions and therapeutic targets
Gary M. Mawe et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
The gastrointestinal mucus system in health and disease
Malin E. V. Johansson et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Video-assisted swallowing therapy for patients with Parkinson's disease
Yael Manor et al.
PARKINSONISM & RELATED DISORDERS (2013)
Probiotic supplementation decreases intestinal transit time: Meta-analysis of randomized controlled trials
Larry E. Miller et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Hypometabolism in the supplementary and anterior cingulate cortices is related to dysphagia in Parkinson's disease: a cross-sectional and 3-year longitudinal cohort study
Akio Kikuchi et al.
BMJ OPEN (2013)
Hirschsprung disease: a developmental disorder of the enteric nervous system
Sonja J. McKeown et al.
WILEY INTERDISCIPLINARY REVIEWS-DEVELOPMENTAL BIOLOGY (2013)
Parkinson's disease is not associated with gastrointestinal myenteric ganglion neuron loss
Dana M. Annerino et al.
ACTA NEUROPATHOLOGICA (2012)
Prolonged Swallowing Time in Dysphagic Parkinsonism Patients With Aspiration Pneumonia
Chia-Wei Lin et al.
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION (2012)
Lubiprostone stimulates small intestinal mucin release
Robert C. De Lisle
BMC GASTROENTEROLOGY (2012)
Increased Intestinal Permeability and Parkinson Disease Patients: Chicken or Egg?
D. Salat-Foix et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2012)
Coadministration of Domperidone Increases Plasma Levodopa Concentration in Patients With Parkinson Disease
Noriko Nishikawa et al.
CLINICAL NEUROPHARMACOLOGY (2012)
Neuromuscular Electrical Stimulation Versus Traditional Therapy in Patients with Parkinson's Disease and Oropharyngeal Dysphagia: Effects on Quality of Life
B. J. Heijnen et al.
DYSPHAGIA (2012)
Effect of Quercetin in the 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-Induced Mouse Model of Parkinson's Disease
Chuanfeng Lv et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2012)
Gastrointestinal Dysfunction in a Parkinson's Disease Rat Model and the Changes of Dopaminergic, Nitric Oxidergic, and Cholinergic Neurotransmitters in Myenteric Plexus
Hong Can Zhu et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2012)
Plasma levodopa peak delay and impaired gastric emptying in Parkinson's disease
Hirokazu Doi et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease
Kathleen M. Shannon et al.
MOVEMENT DISORDERS (2012)
Nonmotor Manifestations in Parkinson Disease
Oscar Bernal-Pacheco et al.
NEUROLOGIST (2012)
Placebo-controlled trial of lubiprostone for constipation associated with Parkinson disease
W. G. Ondo et al.
NEUROLOGY (2012)
Gastroparesis and Parkinson's disease: A systematic review
Zaid S. Heetun et al.
PARKINSONISM & RELATED DISORDERS (2012)
Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort
Mark L. Wahlqvist et al.
PARKINSONISM & RELATED DISORDERS (2012)
Contrasting effects of linaclotide and lubiprostone on restitution of epithelial cell barrier properties and cellular homeostasis after exposure to cell stressors
John Cuppoletti et al.
BMC Pharmacology & Toxicology (2012)
Gastroparesis: Approach, Diagnostic Evaluation, and Management
Derek M. Tang et al.
DM DISEASE-A-MONTH (2011)
Impaired Food Transportation in Parkinson's Disease Related to Lingual Bradykinesia
George Umemoto et al.
DYSPHAGIA (2011)
Respiratory-Swallowing Coordination and Swallowing Safety in Patients with Parkinson's Disease
Michelle S. Troche et al.
DYSPHAGIA (2011)
Clinical Features of Idiopathic Gastroparesis Vary With Sex, Body Mass, Symptom Onset, Delay in Gastric Emptying, and Gastroparesis Severity
Henry P. Parkman et al.
GASTROENTEROLOGY (2011)
Chronic Intestinal Pseudo-Obstruction: Clinical Features, Diagnosis, and Therapy
Roberto De Giorgio et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2011)
Role of flavonoids in intestinal tight junction regulation
Takuya Suzuki et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2011)
Peripheral Lewy body pathology in Parkinson's disease and incidental Lewy body disease: Four cases
Kelly Del Tredici et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Neuroprotective effect of bioflavonoid quercetin in 6-hydroxydopamine-induced oxidative stress biomarkers in the rat striatum
Nagaraja Haleagrahara et al.
NEUROSCIENCE LETTERS (2011)
Increased Intestinal Permeability Correlates with Sigmoid Mucosa alpha-Synuclein Staining and Endotoxin Exposure Markers in Early Parkinson's Disease
Christopher B. Forsyth et al.
PLOS ONE (2011)
The use of abdominal massage to treat chronic constipation
Marybetts Sinclair
JOURNAL OF BODYWORK AND MOVEMENT THERAPIES (2011)
Domperidone and Ventricular Arrhythmia or Sudden Cardiac Death A Population-Based Case-Control Study in the Netherlands
Charlotte van Noord et al.
DRUG SAFETY (2010)
Tegaserod and the Risk of Cardiovascular Ischemic Events: An Observational Cohort Study
Jeanne Loughlin et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2010)
A double-blind, placebo-controlled study of prucalopride in elderly patients with chronic constipation
S. Mueller-Lissner et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2010)
Colonic Biopsies to Assess the Neuropathology of Parkinson's Disease and Its Relationship with Symptoms
Thibaud Lebouvier et al.
PLOS ONE (2010)
Risk of serious ventricular arrhythmia and sudden cardiac death in a cohort of users of domperidone: a nested case-control study
Catherine B. Johannes et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2010)
Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators
T. Piche et al.
GUT (2009)
Enteric neuroglial apoptosis in inflammatory bowel diseases
Gabrio Bassotti et al.
JOURNAL OF CROHNS & COLITIS (2009)
Swallowing problems in Parkinson disease: frequency and clinical correlates
N. Miller et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)
The Priamo Study: A Multicenter Assessment of Nonmotor Symptoms and Their Impact on Quality of Life in Parkinson's Disease
Paolo Barone et al.
MOVEMENT DISORDERS (2009)
Neurochemical plasticity in the enteric nervous system of a primate animal model of experimental Parkinsonism
T. Chaumette et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2009)
Intestinal mucosal barrier function in health and disease
Jerrold R. Turner
NATURE REVIEWS IMMUNOLOGY (2009)
Cisapride and ventricular arrhythmia
Sean Hennessy et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Parkinson's disease and the gut: a well known clinical association in need of an effective cure and explanation
G. Natale et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2008)
A pilot study of respiration and swallowing integration in Parkinson's disease: On and Off levodopa
Anthony Lim et al.
DYSPHAGIA (2008)
Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson's disease
Grant Anderson et al.
EXPERIMENTAL NEUROLOGY (2007)
Serotonin and neuroprotection in functional bowel disorders
M. D. Gershon et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2007)
Macrogol for the treatment of constipation in Parkinson's disease. A randomized placebo-controlled study
Roberta Zangaglia et al.
MOVEMENT DISORDERS (2007)
The serotonin signaling system: From basic understanding to drug development-for functional GI disorders
Michael D. Gershon et al.
GASTROENTEROLOGY (2007)
Identification of neurons that express 5-hydroxytryptamine4 receptors in intestine
Daniel P. Poole et al.
CELL AND TISSUE RESEARCH (2006)
Excess burden of constipation in Parkinson's disease: A pilot study
Julie Kaye et al.
MOVEMENT DISORDERS (2006)
Predictors of gastric emptying in Parkinson's disease
O Goetze et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2006)
Gastric α-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology
H Braak et al.
NEUROSCIENCE LETTERS (2006)
Non-motor symptoms of Parkinson's disease: diagnosis and management
KR Chaudhuri et al.
LANCET NEUROLOGY (2006)
Salivary production in Parkinson's disease
M Proulx et al.
MOVEMENT DISORDERS (2005)
Glucagon-like peptide 2 (GLP-2), an intestinotrophic mediator
J Thulesen
CURRENT PROTEIN & PEPTIDE SCIENCE (2004)
Factors of importance for weight loss in elderly patients with Parkinson's disease
B Lorefält et al.
ACTA NEUROLOGICA SCANDINAVICA (2004)
Life style risks of Parkinsons disease: Association between decreased water intake and constipation
A Ueki et al.
JOURNAL OF NEUROLOGY (2004)
Parkinsonian signs and substantia nigra neuron density in decendents elders without PD
GW Ross et al.
ANNALS OF NEUROLOGY (2004)
Swallowing disorders in Parkinson's disease
A Potulska et al.
PARKINSONISM & RELATED DISORDERS (2003)
Idiopathic Parkinson's disease:: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen
H Braak et al.
JOURNAL OF NEURAL TRANSMISSION (2003)
Genomic medicine: Alzheimer's disease and Parkinson's disease
RL Nussbaum et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Constipation - modern laxative therapy
E Klaschik et al.
SUPPORTIVE CARE IN CANCER (2003)
Autonomic dysfunction in Parkinson's disease: a comprehensive symptom survey
MF Siddiqui et al.
PARKINSONISM & RELATED DISORDERS (2002)
Macrogol 3350/electrolyte improves constipation in Parkinson's disease and multiple system atrophy
TE Eichhorn et al.
MOVEMENT DISORDERS (2001)
Frequency of bowel movements and the future risk of Parkinson's disease
RD Abbott et al.
NEUROLOGY (2001)
Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder
EP Bouras et al.
GASTROENTEROLOGY (2001)
The interaction of visual and proprioceptive inputs in pointing to actual and remembered targets in Parkinson's disease
SV Adamovich et al.
NEUROSCIENCE (2001)
分享论文
